Join
Live feed
·
INSIDERFilingvia Quantisnow
Kiromic BioPharma Inc. logo

SEC Form 4: Chiriva Internati Maurizio bought $10,357 worth of Common Stock (2,800 units at $3.70), increasing direct ownership by 0.20% to 1,378,072 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KRBP (Kiromic BioPharma Inc.) and more on Quantisnow.